Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06963931 · ClinicalTrials.gov registry record · NA
Change 4 Better (C4B)
A NA study of Problem Gambling, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 4
- Study locations
NCT06963931: Recruiting NA study of Problem Gambling, sponsored by Yale University.
NCT06963931 is a NA study of Problem Gambling that is actively recruiting participants, run by Yale University. The registered enrollment target is 128 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06963931, a NA study of Problem Gambling, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this research study is to determine the effectiveness of the Change4Better (C4B) mobile app at reducing the severity of problem gambling as compared to standard treatment as usual (TAU).
Primary Outcome
Change in gambling symptom severity as measured monthly by the Gambling Symptom Assessment Scale (G-SAS) from baseline to 6 months. Each item is scored on a 5-point scale from 0 (no symptoms) to 4 (extreme symptoms). The total score ranges from 0 to 48.
Conditions Studied
Interventions
- BEHAVIORAL Change4Better (C4B) mobile app
Study Locations (4)
Connecticut
- CommuniCare - New Haven
- Connecticut Renaissance - Norwalk
- United Community & Family Services - Norwich
- MCCA - Waterbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT06963931 shows while recruiting
NCT06963931 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Problem Gambling appearing as the primary indexed condition, and to 1 intervention - of which Change4Better (C4B) mobile app is the first listed.
NCT06963931 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06963931 about?
NCT06963931 is a clinical study titled "Change 4 Better (C4B)". The purpose of this research study is to determine the effectiveness of the Change4Better (C4B) mobile app at reducing the severity of problem gambling as compared to standard treatment as usual (TAU).
What is the current status of trial NCT06963931?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-05-01. Estimated completion is 2027-12.
What conditions does trial NCT06963931 study?
This clinical trial studies the following conditions: Problem Gambling.
What interventions are being tested in trial NCT06963931?
The interventions under investigation include: Change4Better (C4B) mobile app (BEHAVIORAL).
Who is sponsoring clinical trial NCT06963931?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06963931 being conducted?
This trial has 4 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Problem Gambling
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06963931's enrollment target sits among peer trials
128 744th of 2000 higher than 1,252 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI